Results 181 to 190 of about 747,551 (253)

A Scoping Review on Exercise Interventions During Adjuvant Chemotherapy or Radiotherapy for Cancer. [PDF]

Cureus
Nair T, Mehta C, Kumar PG.
europepmc   +1 more source

The potential impact of H1 antihistamines on clinical outcomes in NSCLC patients undergoing EGFR‐TKIs treatment

British Journal of Clinical Pharmacology, EarlyView.
Background Epidermal growth factor receptor–tyrosine kinase inhibitors (EGFR‐TKIs) have substantially improved outcomes in non‐small cell lung cancer (NSCLC); however, the development of treatment resistance remains a major clinical challenge. This study examines the association between concomitant prescriptions of H1‐antihistamines (H1AHs) and ...
Van Thuan Nguyen, Ngoc Hoang Le, Nhu Quynh Phan, Toan Trung Duong, Le Thi Anh Thu, Hsuan‐Chia Yang, Chih‐Wei Huang, Min‐Huei Hsu, Jason C. Hsu, Chien‐Tien Su, Phung‐Anh Nguyen   +10 more
wiley   +1 more source

Efficacy and tolerability of scalp cooling in preventing alopecia during (neo)adjuvant chemotherapy for breast cancer. [PDF]

Pathol Oncol Res
Sántha D, Dobi Á, Iványi M, Válóczi D, Varga Z, Oláh J, Nikolényi A.   +6 more
europepmc   +1 more source

What Makes an “Ideal” Cell Line for Recombinant Adeno‐Associated Virus Production?

Biotechnology and Bioengineering, EarlyView.
Several host cell types have been used to produce rAAVs to date. Cell line‐specific traits that are beneficial in the context of rAAV manufacturing are reviewed here, with the goal of developing a consensus on the ‘ideal’ characteristics that an rAAV production host should possess (created with Biorender.com).
James Conheady, Nicholas Donohue, Alexandra Bogdanovic, Sharon Davin, Brian Glennon, Niall Barron, C. Mark Smales   +6 more
wiley   +1 more source

Adjuvant Chemotherapy ± Chemoradiotherapy for Adenocarcinoma of the Pancreatic Head: Results of the Radiotherapy Random Assignment of NRG Oncology/RTOG 0848. [PDF]

J Clin Oncol
Abrams RA, Winter KA, Goodman KA, Regine WF, Safran HP, Guha CS, Kachnic LA, Gillin MT, Philip PA, Lowy AM, O'Reilly E, Van Laethem JL, Seaward SA, Wu AJ, Wu JJ, Aljumaily RM, DiPetrillo TA, Geva R, Anne PR, Liles DK, Ling DC, Conlin A, Moughan J, Crane CH.   +23 more
europepmc   +1 more source

Cell and Gene Therapies Manufacturing Challenges and Integrated Good Manufacturing Practices Solutions: A Lifecycle Perspective

Biotechnology and Bioengineering, EarlyView.
Lifecycle perspective on cell and gene therapy manufacturing challenges and enabling GMP solutions. ABSTRACT Cell and gene therapies (CGTs) are revolutionizing modern medicine; however, making these advanced medicines scalable and readily available to commercial manufacturers worldwide is a major challenge. The number of approved CGT products continues
Rajath Samaga, Udisha Singh, Sachin Dattram Pawar   +2 more
wiley   +1 more source

Microbiomic and immunogenic biomarkers of adjuvant chemotherapy efficacy in stage III colorectal cancer. [PDF]

JNCI Cancer Spectr
Machida E, Takamizawa Y, Takayanagi D, Cho H, Shida D, Yamada M, Asami Y, Ono H, Takeuchi M, Hamamoto R, Rikiyama T, Suzuki K, Kanemitsu Y, Kohno T, Takashima A, Sekine S, Shiraishi K.   +16 more
europepmc   +1 more source

Adjuvant chemotherapy in elderly colon cancer patients: when less may be more. [PDF]

J Gastrointest Oncol
Eslinger C, Sonbol MB.
europepmc   +1 more source

Integrated spherical nucleic acid nanoreactor mobilizes targeted PD‐L1 proteolysis and cuproptosis for robust breast cancer immunotherapy

BMEMat, EarlyView.
This study provides an integrated spherical nucleic acid nanoreactor (denoted as AMCuD) for targeted PD‐L1 degradation and chemo‐dynamically enhanced cuproptosis to synergically elicit robust immunotherapy against the triple‐negative breast cancer (TNBC) growth, recurrence and metastasis.
Ningxi Li, Honglin Huang, Qianyi Zeng, Li Zeng, Ziman Yang, Jinyang Shen, Shun Li, Hong Yang, Yiyao Liu, Chunhui Wu   +9 more
wiley   +1 more source

Contemporary Adjuvant Chemotherapy for Intraductal Papillary Mucinous Neoplasms.

JAMA Netw Open
Lucocq J, Haugk B, White S, Marchegiani G, Holmberg M, Zerbi A, Pagnanelli M, Lu Z, Inoue Y, Choi M, Kang CM, Visser B, Corpelijn L, Andersson B, Bereza-Carlson P, Björnsson B, Wennerblom J, Labori KJ, Goh BKP, Hartman V, Ahmad S, Patel S, Berrevoet F, Mortensen K, Roberts K, Ausania F, Lynch C, Gupta A, Bertrand C, Kleeff J, Addeo P, Bellotti R, Ven Fong Z, Friess H, Koea J, Gomez D, Gordon-Weeks A, Doria C, Tzimas G, Franklin O, Månsson C, Cabús SS, Bhogal RH, Pathak S, Honselmann KC, Balakrishnan A, Harrison E, Mann K, Gill AJ, Mittal A, Samra J, Athwal T, Loveday B, Teh C, Bhardwaj N, Menon K, Thapa P, Matsumoto I, Jamieson N, Rebours V, Descourvieres C, Davidson B, Soreide K, Pandanaboyana S, Adeno-IPMN2 Collaborative.   +64 more
europepmc   +1 more source